During the course of our screening for novel and potent antifungal agents active against phytopathogenic fungi, we isolated two new members of azalomycin class, 2-demethylazalomycin F4a (1) and 2-demethylazalo-
properties of 1 and 2.
Strain HIL Y-9120362 was isolated from a soil sample collected from Madhya Pradesh, India. A loopful of mature slant culture of Y-9120362was inoculated into Erlenmeyer flasks (1 liter capacity) containing 150 ml of seed mediumconsisting of glucose 1.5%, soyabean meal 1.5%, corn steep liquor 0.5%, NaCl 0.5%, CaCO3 0.2%, p.H 7.0 before autoclaving. The flasks were cultivated on a rotary shaker at 220 rpm for 72 hours. The seed culture (3 liters) was inoculated into a 150-liter fermentor containing 90 liters of the production medium consisting of soluble starch 2.5%, glucose 1.0%, soyabean meal 2.0%, yeast extract 0.5%, NaCl 0.5%, CaCO3 0.3% and 2-Demethylazalomycin F4a (1): R=H 2-Demethylazalomycin F5a (2): R=CH3
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MgSO4-7H2O 0.1%, pH 7.0 before autoclaving. The aeration and agitation of the fermentation were maintained at 60 liters per minute and 100rpm, respectively, and the temperature at 28°C. Desmophen was added as the antifoam during the fermentation cycle of 44 hours. The production of the antibiotic as well as its purification were monitored by activity against Fusarium culmorium 100. The culture broth was harvested and centrifuged to separate the mycelium (6kg). The culture filtrate (75 liters) was passed through a column of Diaion HP-20 (4 liters). The column was washed with demineralized water and eluted with MeOH. The active eluates were concentrated under reduced pressure to give crude antibiotic (41 g) as brown powder. The mycelium was extracted with MeOH(2 x 10 liters), concentrated, diluted with water, passed through HP-20 (1 liter) and processed further as above to get additional crude antibiotic (27 g). Both the crude materials were combined and subjected to MPLCon RP-18 (50-70//) using a step gradient of 0-70% (in increments of5%) CH3CN-MeOH(1 : 1) in 0.02m phosphate buffer, pH 5.8. The active fractions, which eluted out in 40-50% CH3CN-MeOH(1 : 1) in 0.02 m phosphate buffer, were pooled, concentrated and desalted on HP-20 (eluant-MeOH).The concentrated active fractions were subjected to silica gel (55-75/i) chromatography using a step gradient of 0-2% water (in increments of 0.5%) in EtOAc-rc-PrOH (5 : 3). All the fractions were monitored by their bioactivity and also by HPLC (Column: 4mmx(30+100) mm ODSHypersil (10 //); Eluant: CH3CN-MeOH-0. 1 % NH4H2-PO4 (14: ll : 10); Flow rate: 1.5ml/minute; Detection: 240nm).
The semi-pure 1 (6.2g) and 2 (5g), thus obtained, were purified separately by preparative HPLC (Column: 16mm x (30+ 120) mm ODS-Hypersil (10/i);
Eluant: CH3CN-MeOH-0.1% NH4H2PO4 (14:ll: 10); Flow rate: 9ml/minute; Detection: 240nm) to obtain pure 1 (2.2g) and 2 (3.8g). Both 1 and 2 were obtained as white powders and found to be soluble in MeOHand DMSO.
The physico-chemical properties of 1 and 2 are given in Table 1 . The UVabsorption maxima of both the compounds 1 and 2 were indicative of a conjugated diene and a, /?, y, (5-unsaturated conjugated carbonyl moiety.
IR bands at 3380, 1700, 1645 and 975cm"1 in case of1 and correspondingly at 3400, 1710, 1645 and 975cm"1 in case of 2 were suggestive of the presence of hydroxyls, carbonyls and mms-disubstituted double bonds. The *H NMRspectrum of1 is given in Fig. 1 . The XH NMRof 2 was practically identical to that of 1 except that the N-methyl signal (5 2.88) was twice as intense.
The 13C NMRand DEPT-135 spectra of both the compounds revealed the presence of 6 x CH3, 16 x CH2, 5xCH, 12xOCH, 9x=CH,3xCand 3xC=O, inaddition to one N-CH3 in case of 1 and two N-CH3 in VOL.48 NO.ll Table 1 . Physico-chemical properties of 2-demethylazalomycin F4a (1) and 2-demethylazalomycin F5a (2). case of 2. The molecular formulae of 1 and 2 required eleven degrees of unsaturation, out of which only nine were accountable in the form of six double bonds and three carbonyls, indicating that both the compounds contained two rings.
The XH and 13C NMRdata of1 and 2 indicated that they were macrocyclic lactones like azalomycins F4aX) and F5a2). Whereas azalomycins F4a and F5a had seven C-methyl groups, *H and 13C NMRof1 and 2 accounted only for six C-methyls. Thus, C-2 methyl, which appeared at dc 12.8 and Su 1.98 in azalomycins F4a and F5a, was absent in 1 and 2. Instead, XHNMRspectra of 1 and 2 indicated the presence of an additional olefinic proton at d 5.86 (d, /= 15.6Hz) having a correlation with 3-H (5 7.23, dd, /= 15.6, ll Hz) in its DQF shift-correlated HHCOSYspectrum. Further, an additional olefinic methine doublet at 5 121A in 13C NMRspectrum of 1 and 2 coupled with the absence of an olefinic quaternary carbon singlet, which is observed at S 126.7 in that of azalomycin F4a and F5a suggested that both 1 and 2 were 2-demethylazalomycins.
The position of the two N-CH3 groups (dH 2.89, 6H) in 2 as a part of either N,N-dimethylguanidine or N,N'-dimethylguanidine was determined2) by alkaline hydrolysis (3n NaOH, reflux, 6 hours, N2/HC1) of 2, followed by treating the amine hydrochloride with benzoyl chloride.
The product, thus obtained, was identified as N-methylbenzamide, indicating the presence (97) 12 (97) 17 (97) 13 (97) 13 (75) 15 (40) NT (95) NT (65) *Zone size in mm at a concentration of 5/ig/disc; **Protection in % at 150ppm under green house conditions; NT: not tested.
of N,N'-dimethylguanidine moiety in 2.
The stereochemistries of the double bonds were established on the basis of coupling constants and by the analysis of phase-sensitive 2D NOESYspectrum. In the *H NMRspectra of 1 and 2, the large coupling constants between 2-H (5 5.86) and 3-H (5 7.23) (/= 15.6Hz), 4-H (S 6.32) and 5-H (S 6.16) (/= 15.8Hz) and 32-H (S 6.26) and 33-H (5 5.46) (/=14.8Hz) indicated that these double bonds were oriented in Is-configuration. The stereochemistry of C-40=C-41 double bond could not be established due to overlapping signals; however, considering the identity of the spectra with those reported in literature1>2), it is assumed to be E. Based on these data, it can be concluded that 1 and 2 are 2-demethylazalomycin F4a and 2-demethylazalomycin F5a respectively. 1 was isolated by us earlier from another culture Y-85212423). During the course of this work, we came across a report4) on MDL63766 complex belonging to the azalomycin class. One of the components was reported to have the same molecular weight of 1081 as in the case of 2. However, the structure of this compoundhas not been reported. Subsequent to the preparation of this manuscript, two compounds RS-22B NOV. 1995 and RS-22C, which are identical to 1 and 2, have been reported5*. Biological Properties Both the compounds 1 and 2 exhibited "in vitro" and "in vivo" activity against a wide range of fungal strains (Table 2) . They did not exhibit any antibacterial activity.
